{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,11]],"date-time":"2026-04-11T01:19:05Z","timestamp":1775870345919,"version":"3.50.1"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2005,11,3]],"date-time":"2005-11-03T00:00:00Z","timestamp":1130976000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cancer Immunol Immunother"],"published-print":{"date-parts":[[2006,7]]},"DOI":"10.1007\/s00262-005-0080-z","type":"journal-article","created":{"date-parts":[[2005,11,2]],"date-time":"2005-11-02T15:24:54Z","timestamp":1130945094000},"page":"830-840","source":"Crossref","is-referenced-by-count":35,"title":["T lymphocyte chemotactic chemokines in acute myelogenous leukemia (AML): local release by native human AML blasts and systemic levels of CXCL10 (IP-10), CCL5 (RANTES) and CCL17 (TARC)"],"prefix":"10.1007","volume":"55","author":[{"given":"Astrid Marta","family":"Olsnes","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dmitri","family":"Motorin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anita","family":"Ryningen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrey Y.","family":"Zaritskey","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"\u00d8ystein","family":"Bruserud","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2005,11,3]]},"reference":[{"key":"80_CR1","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1056\/NEJM199909303411407","volume":"341","author":"B L\u00f6wenberg","year":"1999","unstructured":"L\u00f6wenberg B, Downing JR, Burnett A (1999) Acute myeloid leukemia. N Engl J Med 341:1051\u20131062","journal-title":"N Engl J Med"},{"key":"80_CR2","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1038\/sj.leu.2401452","volume":"13","author":"\u00d8 Bruserud","year":"1999","unstructured":"Bruserud \u00d8 (1999) Acute myelogenous leukemia blasts as accessory cells during T lymphocyte activation: possible implications for future therapeutic strategies. Leukemia 13:1175\u20131187","journal-title":"Leukemia"},{"key":"80_CR3","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1634\/stemcells.18-3-157","volume":"18","author":"\u00d8 Bruserud","year":"2000","unstructured":"Bruserud \u00d8, Gjertsen BT (2000) New strategies for the treatment of acute myelogenous leukemia: differentiation induction \u2013 present use and future possibilities. Stem Cells 18:157\u2013165","journal-title":"Stem Cells"},{"key":"80_CR4","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1517\/14712598.1.6.1005","volume":"1","author":"\u00d8 Bruserud","year":"2001","unstructured":"Bruserud \u00d8, Wendelbo \u00d8 (2001) Biological treatment of acute myelogenous leukemia: how should T cell targeting immunotherapy be combined with intensive chemotherapy. Exp Opin Biol Ther 1:1005\u20131016","journal-title":"Exp Opin Biol Ther"},{"key":"80_CR5","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1006\/cimm.2000.1725","volume":"206","author":"\u00d8 Bruserud","year":"2000","unstructured":"Bruserud \u00d8, Ulvestad E (2000) Acute myelogenous leukemia blasts as accessory cells during in vitro T lymphocyte activation. Cell Immunol 206:35\u201350","journal-title":"Cell Immunol"},{"key":"80_CR6","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1038\/84205","volume":"2","author":"SA Luther","year":"2001","unstructured":"Luther SA, Cyster JG (2001) Chemokines as regulators of T cell differentiation. Nat Immunol 2:102\u2013107","journal-title":"Nat Immunol"},{"key":"80_CR7","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1016\/S0161-5890(02)00013-5","volume":"38","author":"S Romagnani","year":"2001","unstructured":"Romagnani S (2001) Cytokines and chemoattractants in allergic inflammation. Mol Immunol 38:881\u2013885","journal-title":"Mol Immunol"},{"key":"80_CR8","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1093\/intimm\/11.1.81","volume":"11","author":"T Imai","year":"1999","unstructured":"Imai T, Nagira M, Takagi S et\u00a0al (1999) Selective recruitment of CCR4-bearing Th2 cells toward antigen-presenting cells by the CC chemokines thymus and activation-regulated chemokine and macrophage-derived chemokine. Int Immunol 11:81\u201388","journal-title":"Int Immunol"},{"key":"80_CR9","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.it.2003.12.005","volume":"25","author":"B Moser","year":"2004","unstructured":"Moser B, Wolf M, Walz A, Loetscher P (2004) Chemokines: multiple levels of leukocyte migration control. Trends Immunol 25:75\u201384","journal-title":"Trends Immunol"},{"key":"80_CR10","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/S1359-6101(97)00015-4","volume":"8","author":"LF Neville","year":"1997","unstructured":"Neville LF, Mathiak G, Bagasra \u00d8 (1997) The Immunobiology of Interferon-gamma Inducible Protein 10\u00a0kD (IP-10): a novel, pleiotropic member of the C-X-C chemokine superfamily. Cytokine Growth F R 8:207\u2013219","journal-title":"Cytokine Growth F R"},{"key":"80_CR11","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1007\/s00262-004-0505-0","volume":"53","author":"\u00d8 Wendelbo","year":"2004","unstructured":"Wendelbo \u00d8, Nesthus I, Sjo M, Paulsen K, Ernst P, Bruserud \u00d8 (2004) Functional characterization of T lymphocytes derived from patients with acute myelogenous leukemia and chemotherapy-induced leukopenia. Cancer Immunol Immun 53:740\u2013747","journal-title":"Cancer Immunol Immun"},{"key":"80_CR12","first-page":"416","volume":"88","author":"\u00d8 Bruserud","year":"2003","unstructured":"Bruserud \u00d8, Hovland R, Wergeland L, Huang T-s, Gjertsen BT (2003) Flt3-mediated signalling in human acute myelogenous leukemia (AML) blasts: a functional characterization of the effects of Flt3-ligand in AML cell populations with and without Flt3 abnormalities. Haematologica 88:416\u2013428","journal-title":"Haematologica"},{"key":"80_CR13","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1046\/j.1365-2141.1999.01684.x","volume":"107","author":"K Wheatley","year":"1999","unstructured":"Wheatley K, Burnett AK, Goldstone AH et\u00a0al (1999) A simple, robust, validated and highly predictive index for the determination of risk-directed therapy in acute myeloid leukemia derived from the MRC AML 10 trial. Br J Haematol 107:69\u201379","journal-title":"Br J Haematol"},{"key":"80_CR14","first-page":"1783","volume":"9","author":"MC Bene","year":"1995","unstructured":"Bene MC, Castoldi G, Knapp W et\u00a0al (1995) Proposals for the immunological classification of acute leukemias. Leukemia 9:1783\u20131786","journal-title":"Leukemia"},{"key":"80_CR15","first-page":"391","volume":"89","author":"\u00d8 Bruserud","year":"2004","unstructured":"Bruserud \u00d8, Ryningen A, Wergeland L, Glenjen NI, Gjertsen BT (2004) Osteoblasts increase proliferation and release of proangiogenic interleukin 8 by native human acute myelogenous leukemia blasts. Haematologica 89:391\u2013402","journal-title":"Haematologica"},{"key":"80_CR16","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1634\/stemcells.19-1-1","volume":"19","author":"\u00d8 Bruserud","year":"2001","unstructured":"Bruserud \u00d8, Gjertsen BT, Foss B, Huang T-s (2001) New strategies in the treatment of acute myelogenous leukemia (AML): in vitro culture of AML cells\u2013the present use in experimental studies and the possible importance for future therapeutic strategies. Stem Cells 19:1\u201311","journal-title":"Stem Cells"},{"key":"80_CR17","first-page":"24","volume":"741","author":"\u00d8 Bruserud","year":"2005","unstructured":"Bruserud \u00d8, Tronstad KJ, Berge R (2005) In vitro culture of human osteosarcoma cell lines: a comparison of functional characteristics for cell lines cultured in medium without and with fetal calf serum. J Cancer Res Clin Oncol 741:24\u201334","journal-title":"J Cancer Res Clin Oncol"},{"key":"80_CR18","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1034\/j.1600-0609.2003.02766.x","volume":"70","author":"N Rochet","year":"2003","unstructured":"Rochet N, Leroy P, Far DF, Ollier L, Loubat A, Rossi B (2003) CAL72: a human osteosarcoma cell line with unique effects on hematopoietic cells. Eur J Haematol 70:43\u201352","journal-title":"Eur J Haematol"},{"key":"80_CR19","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.leukres.2004.06.008","volume":"292","author":"A Ryningen","year":"2005","unstructured":"Ryningen A, Wergeland L, Glenjen NI, Gjertsen BT, Bruserud \u00d8 (2005) In vitro crosstalk between fibroblasts and native human acute myelogenous leukemia (AML) blasts via local cytokine networks results in increased proliferation and decreased apoptosis of AML cells as well as increased levels of proangiogenic Interleukin 8. Leukemia Res 292:185\u2013196","journal-title":"Leukemia Res"},{"key":"80_CR20","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1111\/j.1600-0609.2004.00307.x","volume":"73","author":"\u00d8 Bruserud","year":"2004","unstructured":"Bruserud \u00d8, Wendelbo \u00d8, Paulsen K (2004) Lipoteichoic acid derived from Enterococcus faecalis modulates the functional characteristics of both normal peripheral blood leukocytes and native human acute myelogenous leukemia blasts. Eur J Haematol 73:340\u2013350","journal-title":"Eur J Haematol"},{"key":"80_CR21","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1002\/ijc.20353","volume":"111","author":"NI Glenjen","year":"2004","unstructured":"Glenjen NI, Ersv\u00e6r E, Ryningen A, Bruserud \u00d8 (2004) In vitro effects of native human acute myelogenous leukemia blasts on fibroblasts and osteoblasts. Int J Cancer 111:858\u2013867","journal-title":"Int J Cancer"},{"key":"80_CR22","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1002\/cyto.b.20044","volume":"64","author":"AM \u00d8yan","year":"2005","unstructured":"\u00d8yan AM, Bo TH, Jonassen I et\u00a0al (2005) CD34 expression in native human acute myelogenous leukemia blasts: Differences in CD34 membrane molecule expression are associated with different gene expression profiles. Cytometry B Clin Cytom 64:18\u201327","journal-title":"Cytometry B Clin Cytom"},{"key":"80_CR23","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1089\/15258160260090933","volume":"11","author":"BT Gjertsen","year":"2002","unstructured":"Gjertsen BT, \u00d8yan AM, Marzolf B et\u00a0al (2002) Analysis of acute myelogenous leukemia: preparation of samples for genomic and proteomic analyses. J Hematother Stem Cell Res 11:469\u2013481","journal-title":"J Hematother Stem Cell Res"},{"key":"80_CR24","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1089\/152581600750062372","volume":"9","author":"\u00d8 Bruserud","year":"2000","unstructured":"Bruserud \u00d8, Gjertsen BT, von Volkman HL (2000) In vitro culture of human acute myelogenous leukemia (AML) cells in serum-free media: studies of native AML blasts and AML cell lines. J Hematother Stem Cell Res 9:923\u2013932","journal-title":"J Hematother Stem Cell Res"},{"key":"80_CR25","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1111\/j.1600-0609.2004.00333.x","volume":"74","author":"\u00d8 Bruserud","year":"2005","unstructured":"Bruserud \u00d8, Glenjen NI (2005) Coculture of native human acute myelogenous leukemia blasts with fibroblasts and osteoblasts results in an increase of vascular endothelial growth factor levels. Eur J Haematol 74:24\u201334","journal-title":"Eur J Haematol"},{"key":"80_CR26","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1080\/713773647","volume":"10","author":"AR Gear","year":"2003","unstructured":"Gear AR, Camerini D (2003) Platelet chemokines and chemokine receptors: linking hemostasis, inflammation, and host defense. Microcirculation 10:335\u2013350","journal-title":"Microcirculation"},{"key":"80_CR27","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1038\/sj.leu.2402835","volume":"17","author":"N Panoskaltsis","year":"2003","unstructured":"Panoskaltsis N, Reid CD, Knight SC (2003) Quantification and cytokine production of circulating lymphoid and myeloid cells in acute myelogenous leukaemia. Leukemia 17:716\u2013730","journal-title":"Leukemia"}],"container-title":["Cancer Immunology, Immunotherapy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00262-005-0080-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00262-005-0080-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00262-005-0080-z","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,24]],"date-time":"2019-05-24T16:32:59Z","timestamp":1558715579000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00262-005-0080-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,11,3]]},"references-count":27,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2006,7]]}},"alternative-id":["80"],"URL":"https:\/\/doi.org\/10.1007\/s00262-005-0080-z","relation":{},"ISSN":["0340-7004","1432-0851"],"issn-type":[{"value":"0340-7004","type":"print"},{"value":"1432-0851","type":"electronic"}],"subject":[],"published":{"date-parts":[[2005,11,3]]}}}